A First-in-Class vIRF3-Derived Peptide (VDP) Therapy Targeting the PKM2 Metabolic Axis for Tumor Regression and Metastasis Inhibition.
Patents for licensing
Filter Technology Offers
Featured
Category
Topic
Country
Showing all visible results for Cytology, Cancerology, Oncology